Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD ▼ | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cellectar BioSciences Inc. | -3.270% | 2.759% | -14.857% | 125.758% | 30.702% | -73.628% | - |
| Immutep LTD ADR | 2.960% | 12.903% | 8.527% | 90.476% | 28.440% | -2.778% | -2.439% |
| Vanda Pharmaceuticals | 1.960% | 11.659% | 19.712% | -20.952% | 28.351% | -63.650% | - |
| Medpace Holdings Inc | -1.500% | -3.454% | -4.249% | 89.391% | 28.327% | 165.147% | - |
| Daiichi Sankyo Co Ltd | -0.970% | 1.702% | 10.657% | 3.700% | 27.960% | 48.616% | - |
| Catalent Inc. | 0.340% | 0.459% | 0.632% | 63.484% | 27.573% | -40.610% | 26.957% |
| Quantum Genomics S.A. | 1.820% | 1.818% | 28.736% | -20.228% | 27.273% | -96.896% | - |
| Avid Bioservices Inc | - | 8.392% | 33.621% | -52.160% | 27.049% | -53.313% | 96.277% |
| Organigram Holdings Inc. | -1.550% | -17.558% | -18.504% | -13.545% | 26.667% | -81.957% | -93.413% |
| Polynovo Ltd | 3.280% | 4.132% | -5.263% | 43.182% | 26.633% | -28.000% | - |
| Krystal Biotech | 0.830% | 1.137% | -11.646% | 83.500% | 26.552% | - | - |
| Anika Therapeutics | 0.780% | 6.612% | 9.322% | 11.207% | 26.471% | -23.669% | -27.160% |
| Novo Nordisk A/S ADR | -0.420% | -1.660% | 0.851% | -23.052% | 26.333% | 90.514% | 174.306% |
| Scryb Inc. | -5.260% | 25.806% | -7.143% | -74.000% | 25.000% | -90.580% | - |
| AnaptysBio Inc | 1.690% | 5.263% | 26.316% | 25.654% | 23.711% | 11.111% | - |
| Genomma Lab International | 0.550% | 2.809% | 8.929% | 22.000% | 23.649% | 12.270% | 27.615% |
| X4 Pharmaceuticals, Inc. | 0.590% | -8.673% | -19.237% | -34.899% | 23.526% | - | - |
| Collegium Pharmaceutical Inc | -1.170% | -1.744% | -5.056% | 60.952% | 23.358% | 81.720% | - |
| Fibrogen Inc. | -18.050% | 11.681% | -29.567% | -93.478% | 22.849% | -93.647% | - |
| Blueprint Medicines Corp | -2.000% | 18.169% | 19.934% | 103.213% | 22.667% | 30.952% | - |
| GSK plc ADR | 1.490% | 7.853% | 7.853% | 22.619% | 22.619% | 4.304% | -9.264% |
| United Therapeutics | -1.500% | 10.605% | 11.366% | 26.992% | 22.573% | 46.386% | 174.794% |
| GSK plc | -0.290% | 5.306% | 9.928% | 22.218% | 22.554% | 29.182% | 15.083% |
| Merck & Co. Inc. | -0.490% | -0.331% | 3.431% | 12.082% | 22.437% | 87.180% | 71.453% |
| SELLAS Life Sciences Group Inc | -2.270% | 2.591% | -10.811% | -27.027% | 21.846% | -82.027% | -99.677% |